Herceptin Research - Side-effects, Breast Cancer, Treatment, Therapy

Herceptin Research Today is a free monthly online journal that collates and summarizes the latest research about Herceptin, including details on side-effects, breast cancer, treatment, therapy.


Herceptin Research Today

Home

View Latest Issue

Information About Herceptin

Books on Herceptin

Advertising in Research Today

View Other Research Today Publications



Volume 2 (2005), Issue 2 (February)

  1. Re-evaluation of HER2 status in metastatic breast cancer and tumor-marker guided therapy with vinorelbine and trastuzumab.
    Onkologie, 28(2): 95-7. [Abstract] [Full-text]
  2. The experimental study on the radioimmunotherapy of the nasopharyngeal carcinoma overexpressing HER2/neu in nude mice model with intratumoral injection of 188Re-herceptin.
    Nucl Med Biol, 32(1): 59-65. [Abstract] [Full-text]
  3. Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments.
    Nucl Med Biol, 32(1): 51-8. [Abstract] [Full-text]
  4. A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2.
    J Biol Chem, 280(6): 4656-62. [Abstract] [Full-text]
  5. Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines.
    Br J Cancer, 92(2): 342-9. [Abstract] [Full-text]
  6. The C-neu mammary carcinoma in Oncomice; characterization and monitoring response to treatment with herceptin by magnetic resonance methods.
    MAGMA, 17(3): 260-70. [Abstract] [Full-text]
  7. Liver metastases from breast cancer: management of patients with significant liver dysfunction.
    Cancer Treat Rev, 31(1): 35-48. [Abstract] [Full-text]
  8. Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification.
    Ann Oncol, 16(3): 359-71. [Abstract] [Full-text]
  9. Targeted therapies in breast cancer.
    Breast J, 11: S30-5. [Abstract] [Full-text]
  10. Trap for MAbs: characterization of intact monoclonal antibodies using reversed-phase HPLC on-line with ion-trap mass spectrometry.
    J Am Soc Mass Spectrom, 16(3): 307-11. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Herceptin Research Today. All Rights Reserved.



Herceptin Research Today Archive:

Volume 1 (2004)
  Issue 1 (November)
  Issue 2 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)



Herceptin Books

Avoiding Cancer One Day At A Time: Practical Advice For Preventing Cancer

Avoiding Cancer One Day At A Time: Practical Advice For Preventing Cancer